Susan G. Komen® To Host Race for the Cure in Dallas This October at a New Location: The University of Texas at Dallas, Richardson, TX

Community Event to Support People with Breast Cancer, Raise Funds for Research and Advocacy Takes Place Saturday, October 18^th

DALLAS--(BUSINESS WIRE)--Susan G. Komen^®, the world’s leading breast cancer organization, will convene breast cancer survivors, those living with metastatic breast cancer (MBC) and supporters at the 2025 Dallas North Texas Race for the Cure. This impactful event unites our community and raises money for the mission of Komen.

Komen aims to raise $1.13M at the Dallas North Texas Race for the Cure, generating critical funds that allow Komen to continue its investment in lifesaving work across the country, including promising research that will allow people to live longer lives with better outcomes. This event also funds Komen’s Patient Care Center, a trusted, go-to source for timely, accurate breast health and breast cancer information, support and resources, as well as the work of Komen’s Center for Public Policy to drive state and federal policies that invest in critical programs and ensure streamlined access to affordable, high-quality breast health care.

WHEN: Saturday, October 18, 2025

WHERE: The University of Texas at Dallas, Richardson, TX

WHO: Susan G. Komen supporters, survivors, and those living with metastatic breast cancer

REGISTER: www.komen.org/dallasrace

DETAILS: We look forward to coming together to end breast cancer with you on Saturday, October 18, 2025! Whether you walk, run or participate virtually, ending breast cancer needs all of us.

WHY IT MATTERS: Breast cancer affects 1 in 8 women in the U.S. and 1 in 1,000 men in their lifetime. In 2025 alone, an estimated 316,950 women in the U.S. will be diagnosed with breast cancer and 42,170 women will die from the disease. Approximately 2,800 men will be diagnosed with breast cancer and 510 will die from it. However, some experts say one-third of breast cancer deaths in the U.S. could be prevented with universal access to modern treatments.

In Texas, approximately 23,880 will be diagnosed with breast cancer and 3,330 will die from the disease this year. Susan G. Komen provides direct support to Texans through its Patient Care Center. In fiscal year 2025, Komen provided assistance to 3,711 patients, including $814,400 in financial assistance to eligible people in active treatment or living with metastatic breast cancer.

“The work Komen does for people with breast cancer, survivors and those with increased risk of breast cancer is not possible without the Dallas North Texas Race for the Cure,” said Peter Balyta, Dallas Race chair and Race chair and President, Texas Instruments - Education Technology. “I am proud to be this year’s Race chair and assist the Komen Dallas team in bringing together the North Texas community to help create a world where we do not lose another life to this disease.”

Bank of America is the national presenting sponsor and Lilly, Natera, and Novartis are national series sponsors for the MORE THAN PINK Walk and Race for the Cure events.

Local sponsors include Presenting Sponsor Tom Thumb- Albertsons, and Gold Sponsor Texas Instruments.

About Susan G. Komen^®

Susan G. Komen^® is the world’s leading nonprofit breast cancer organization, working to save lives and end breast cancer forever. Komen has an unmatched, comprehensive 360-degree approach to fighting this disease across all fronts and supporting millions of people in the U.S. and in countries worldwide. We advocate for patients, drive research breakthroughs, improve access to high-quality care, offer direct patient support and empower people with trustworthy information. Founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy’s life, Komen remains committed to supporting those affected by breast cancer today, while tirelessly searching for tomorrow’s cures. Visit komen.org or call 1-877 GO KOMEN. Connect with us on social at www.komen.org/contact-us/follow-us/.